File Download
There are no files associated with this item.
Supplementary
- Citations:
- Appears in Collections:
Article: The economic impact of pandemic influenza in the United States: Priorities for intervention
Title | The economic impact of pandemic influenza in the United States: Priorities for intervention |
---|---|
Authors | |
Issue Date | 1999 |
Citation | Emerging Infectious Diseases, 1999, v. 5, n. 5, p. 659-671 How to Cite? |
Abstract | We estimated the possible effects of the next influenza pandemic in the United States and analyzed the economic impact of vaccine-based interventions. Using death rates, hospitalization data, and outpatient visits, we estimated 89,000 to 207,000 deaths; 314,000 to 734,000 hospitalizations; 18 to 42 million outpatient visits; and 20 to 47 million additional illnesses. Patients at high risk (15% of the population) would account for approximately 84% of all deaths. The estimated economic impact would be US$71.3 to $166.5 billion, excluding disruptions to commerce and society. At $21 per vaccinee, we project a net savings to society if persons in all age groups are vaccinated. At $62 per vaccinee and at gross attack rates of 25%, we project net losses if persons not at high risk for complications are vaccinated. Vaccinating 60% of the population would generate the highest economic returns but may not be possible within the time required for vaccine effectiveness, especially if two doses of vaccine are required. |
Persistent Identifier | http://hdl.handle.net/10722/238003 |
ISSN | 2021 Impact Factor: 16.126 2020 SCImago Journal Rankings: 2.540 |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Meltzer, Martin I. | - |
dc.contributor.author | Cox, Nancy J. | - |
dc.contributor.author | Fukuda, Keiji | - |
dc.date.accessioned | 2017-02-03T02:12:35Z | - |
dc.date.available | 2017-02-03T02:12:35Z | - |
dc.date.issued | 1999 | - |
dc.identifier.citation | Emerging Infectious Diseases, 1999, v. 5, n. 5, p. 659-671 | - |
dc.identifier.issn | 1080-6040 | - |
dc.identifier.uri | http://hdl.handle.net/10722/238003 | - |
dc.description.abstract | We estimated the possible effects of the next influenza pandemic in the United States and analyzed the economic impact of vaccine-based interventions. Using death rates, hospitalization data, and outpatient visits, we estimated 89,000 to 207,000 deaths; 314,000 to 734,000 hospitalizations; 18 to 42 million outpatient visits; and 20 to 47 million additional illnesses. Patients at high risk (15% of the population) would account for approximately 84% of all deaths. The estimated economic impact would be US$71.3 to $166.5 billion, excluding disruptions to commerce and society. At $21 per vaccinee, we project a net savings to society if persons in all age groups are vaccinated. At $62 per vaccinee and at gross attack rates of 25%, we project net losses if persons not at high risk for complications are vaccinated. Vaccinating 60% of the population would generate the highest economic returns but may not be possible within the time required for vaccine effectiveness, especially if two doses of vaccine are required. | - |
dc.language | eng | - |
dc.relation.ispartof | Emerging Infectious Diseases | - |
dc.title | The economic impact of pandemic influenza in the United States: Priorities for intervention | - |
dc.type | Article | - |
dc.description.nature | link_to_subscribed_fulltext | - |
dc.identifier.pmid | 10511522 | - |
dc.identifier.scopus | eid_2-s2.0-0032741256 | - |
dc.identifier.volume | 5 | - |
dc.identifier.issue | 5 | - |
dc.identifier.spage | 659 | - |
dc.identifier.epage | 671 | - |
dc.identifier.issnl | 1080-6040 | - |